U.S. markets closed

  • S&P 500

    4,274.04
    -31.16 (-0.72%)
     

  • Dow 30

    33,980.32
    -171.69 (-0.50%)
     

  • Nasdaq

    12,938.12
    -164.43 (-1.25%)
     

  • Russell 2000

    1,987.31
    -33.22 (-1.64%)
     

  • Crude Oil

    87.29
    +0.76 (+0.88%)
     

  • Gold

    1,776.30
    -13.40 (-0.75%)
     

  • Silver

    19.74
    -0.35 (-1.74%)
     

  • EUR/USD

    1.0181
    +0.0010 (+0.10%)
     

  • 10-Yr Bond

    2.8930
    +0.0690 (+2.44%)
     

  • GBP/USD

    1.2050
    -0.0044 (-0.37%)
     

  • USD/JPY

    135.0640
    +0.8490 (+0.63%)
     

  • BTC-USD

    23,340.42
    -591.15 (-2.47%)
     

  • CMC Crypto 200

    557.23
    -15.58 (-2.72%)
     

  • FTSE 100

    7,515.75
    -20.31 (-0.27%)
     

  • Nikkei 225

    29,222.77
    +353.86 (+1.23%)
     

The S&P 500 Has Room to Rise, Analysts Say. They Still Lowered Their Price Target.

Sabrina Escobar
·2 min read
The S&P 500 Has Room to Rise, Analysts Say. They Still Lowered Their Price Target.

Citi said there could be 'low double digit upside' during the second half and that expectations for higher rates are largely factored into stock prices.

Continue reading

Recommended Stories

  • Warren Buffett Finally Throws In The Towel On 4 Lousy Stocks

    Warren Buffett likes to say his favorite holding period for an S&P 500 stock is forever. But that's definitely not always the case.

  • Ryan Cohen files to sell entire position in Bed Bath & Beyond

    Ryan Cohen filed paperwork with the SEC on Wednesday to sell the entirety of his stake in Bed, Bath & Beyond.

  • Why Shares of Affirm, SoFi, and Upstart Are Falling Today

    The Nasdaq Composite had given up about 1.3% as of this writing. Shares of the digital bank SoFi (NASDAQ: SOFI) also traded more than 6% lower, while shares of the artificial intelligence lender Upstart (NASDAQ: UPST) were down 6.6%. Investors are also trying to determine what kind of recession may be coming in the U.S. later this year or in 2023.

  • Bluebird bio nabs major win with first FDA approval following split

    Somerville gene therapy firm bluebird bio Inc. has scored its first approval from the U.S. Food and Drug Administration following its business split late last year.

  • U.S. to end purchase of COVID-19 vaccines as industry pivots to commercial market

    Vaccines, treatments and tests will soon all be commercially available. But what that means for consumers' out-of-pocket costs is unclear.

  • “Pretty Good Outlook”: 10 Stocks to Buy Now Before the Bull Market Begins

    In this article, we discuss 10 stocks to buy now before the bull market begins. If you want to see more stocks in this selection, check out 5 Stocks to Buy Now Before the Bull Market Begins. JPMorgan Asset Management’s chief global strategist, David Kelly, told Bloomberg on August 12 that stocks could recover and […]

  • Cisco stock pops on fourth-quarter earnings beat

    Yahoo Finance reporter Ines Ferre breaks down Cisco's fourth-quarter earnings results.

  • FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease

    The FDA approved a first-of-its-kind treatment from Bluebird Bio that represents a potential cure for a rare blood disorder at a price of $2.8 million per patient.

  • The Average 401(k) Balance by Age

    How much money people have put away for retirement naturally varies by age. See how your savings stack up.

  • Warren Buffett Loaded Up on These 10 Stocks for the Rest of 2022

    In this article, we discuss the 10 stocks that Warren Buffett loaded up on for the rest of 2022. If you want to see more stocks in this selection, click Warren Buffett Loaded Up on These 5 Stocks for the Rest of 2022. Despite the high inflation and rising rates battering the US economy since […]

  • Jim Cramer Recommends Selling These 10 Stocks in August

    In this article, we discuss the 10 stocks that Jim Cramer recommends selling in August. If you want to read about some more stocks that Jim Cramer recommends selling, go directly to Jim Cramer Recommends Selling These 5 Stocks in August. Jim Cramer, the former hedge fund manager and present host of Mad Money on […]

  • Apple set to unveil iPhone 14 at upcoming September launch event

    Yahoo Finance tech reporter Allie Garfinkle details Apple's plans to unveil its new iPhone 14 at its September launch event.

  • This Is How Many Years an Extra $100K Buys You in Retirement

    Will I outlive my retirement savings? This question dogs many retirement savers who view their accounts, often far shy of $1 million, with dread and fear. After all, aspiring retirees have to plan for longer lifespans, potentially steep medical costs … Continue reading → The post This Chart Shows You How Many Years an Extra $100K Buys You in Retirement appeared first on SmartAsset Blog.

  • Young Bankers Worry About Nights Off Early and Dark Days Ahead

    (Bloomberg) -- On a boat under the Statue of Liberty at happy hour one August Thursday, young Morgan Stanley colleagues sipped champagne and smiled. Two Citigroup Inc. banking analysts left the company’s headquarters by 5:40 p.m. to drink across the street. A young investment-banking analyst who came close to burning out last year now has enough free time to take in Broadway shows.Most Read from BloombergApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesLiz Cheney Prepares for N

  • Investors Heavily Search The Boeing Company (BA): Here is What You Need to Know

    Zacks.com users have recently been watching Boeing (BA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

  • Markets struggle as investors digest Fed minutes, retail stocks mixed amid earnings

    Anchor Seana Smith examines how markets are reacting to the recent Fed meeting meetings, while checking out how major retail stocks are fairing and looking at the intraday sector action.

  • FDA Approves Sale Of OTC Hearing Aids, Furthering Biden Administration's Goal Of Expanded Healthcare Access

    The FDA approved the sale of over-the-counter hearing aids, allowing millions of Americans to buy hearing aids without seeing an audiologist to improve access to hearing aids, which may lower costs for millions of Americans. The rules, which take effect in mid-October, apply to hearing aids for people with mild to moderate hearing loss. The aids will be available directly from stores or online without medical exams, a prescription, or audiologist fitting adjustment. White House National Economic

  • 10 Safe Dividend Stocks with Over 4% Yield

    In this article, we discuss 10 safe dividend stocks with over 4% yield. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Safe Dividend Stocks with Over 4% Yield. During the current market situation, of all the asset classes, dividend stocks seem to perform well this […]

  • Yellen tells IRS to develop modernization plan in 6 months

    Now that President Joe Biden signed Democrats' expansive climate, tax and health care bill into law, U.S. Treasury Secretary Janet Yellen has directed the IRS to develop a plan within six months outlining how the tax agency will overhaul its technology, customer service and hiring processes.

  • Blue Water Vaccines stock jumps on demand for monkeypox treatments

    After announcing that it plans to potentially develop a monkeypox vaccine, Blue Water Vaccines shares are surging.